Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock. Replay the stock market charts of CYCCP day by day back to 2003. Open long and short positions without spending any money. Cyclacel Pharmaceuticals Inc mainly develops targeted medicines for cancer and other proliferative diseases. The company focuses in hematology and oncology-based development pipeline of novel drug candidates.
